Merit Medical COO granted RSUs, surrenders shares

Merit Medical Systems’ chief operating officer Neil W. Peterson reported new equity awards and a related tax share surrender.

Rhea-AI Filing Summary

Merit Medical Systems’ chief operating officer Neil W. Peterson reported new equity awards and a related tax share surrender. He acquired 7,690 restricted stock units that vest in three equal annual installments, each RSU converting into one common share when it vests. He also received 17,002 common shares after the company’s Compensation and Talent Development Committee determined performance conditions under earlier performance stock units granted on 02/28/2023 had been met. To cover payroll and income taxes, he surrendered 6,061 common shares to the company at $78.02 per share, with no open-market sale involved.

Insider Trade Summary

5 transactions reported

Mixed 5 txns

Insider Peterson Neil W.

Role CHIEF OPERATING OFFICER

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, No Par Value	7,690	$0.00	$0.00
Grant/Award	Common Stock, No Par Value	17,002	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock, No Par Value	6,061	$78.02	$473K
holding	Non-qualified stock options (right to buy)	--	--	--
holding	Non-qualified stock options (right to buy)	--	--	--

Holdings After Transaction: Common Stock, No Par Value — 47,000 shares (Direct); Non-qualified stock options (right to buy) — 38,576 contracts (Direct)

Footnotes (5)

1. F1. Represents a grant of restricted stock units ("RSUs"). The RSUs vest in three equal annual installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.
2. F2. These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 02/28/2023.
3. F3. The Reporting Person surrendered 6,061 shares of common stock to the Issuer for payroll and income taxes. No shares were sold in the open market.
4. F4. Becomes exercisable in equal annual installments of 25% commencing 08/19/2022.
5. F5. Becomes exercisable in equal annual installments of 25% commencing 2/28/2024.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did MMSI COO Neil Peterson report on this Form 4?

Neil Peterson reported equity awards and a tax-related share surrender. He received restricted stock units and performance-based shares, then surrendered a portion of common stock back to Merit Medical Systems to satisfy payroll and income tax obligations tied to these awards, without selling shares on the open market.

How many restricted stock units did MMSI grant to Neil Peterson and how do they vest?

Merit Medical granted Neil Peterson 7,690 restricted stock units. These RSUs vest in three equal annual installments on each of the first three anniversaries of the grant date, contingent on his continued service, with each vested RSU delivering one share of common stock upon settlement.

What performance-based shares did Neil Peterson acquire in this MMSI Form 4 filing?

Peterson acquired 17,002 common shares after the Compensation and Talent Development Committee determined that specified conditions under performance stock units granted on 02/28/2023 had been met. Those performance stock units converted into shares once the committee confirmed the achievement of the required performance criteria.

Why did Neil Peterson surrender 6,061 MMSI shares and was it an open-market sale?

He surrendered 6,061 common shares to Merit Medical to cover payroll and income tax liabilities associated with his equity awards, at $78.02 per share. According to the disclosure, no shares were sold in the open market; the shares were delivered directly back to the issuer.

What stock option positions for MMSI does Neil Peterson report after these transactions?

Peterson reports non-qualified stock options to purchase 25,000 and 13,576 shares of Merit Medical common stock. Footnotes state each grant becomes exercisable in 25% annual installments starting on 08/19/2022 and 02/28/2024, respectively, reflecting a standard, time-based vesting schedule for these options.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/02/2026 - 02:03 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Peterson Neil W.

(Last) (First) (Middle)

1600 W MERIT PARKWAY

(Street)

SOUTH JORDAN UT 84095

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MERIT MEDICAL SYSTEMS INC [ MMSI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF OPERATING OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
02/26/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, No Par Value	02/26/2026		A		7,690(1)	A	$0	36,059	D
Common Stock, No Par Value	02/26/2026		A		17,002(2)	A	$0	53,061	D
Common Stock, No Par Value	02/26/2026		F		6,061(3)	D	$78.02	47,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-qualified stock options (right to buy)	$68.33							08/19/2022(4)	08/19/2028	Common Stock	25,000		25,000	D
Non-qualified stock options (right to buy)	$70.58							02/28/2024(5)	02/28/2030	Common Stock	13,576		13,576	D

Explanation of Responses:

1. Represents a grant of restricted stock units ("RSUs"). The RSUs vest in three equal annual installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.

2. These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 02/28/2023.

3. The Reporting Person surrendered 6,061 shares of common stock to the Issuer for payroll and income taxes. No shares were sold in the open market.

4. Becomes exercisable in equal annual installments of 25% commencing 08/19/2022.

5. Becomes exercisable in equal annual installments of 25% commencing 2/28/2024.

	/s/ Brian G.Lloyd, Attorney-in-Fact	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.